Peripheral Arterial Disease in Patients With End-Stage Renal Disease
Authors:
- Sanjay RajagopalanSRSanjay Rajagopalan
- Santo DellegrottaglieSDSanto Dellegrottaglie
- Anna L. FurnissAFAnna L. Furniss
- Brenda W. GillespieBGBrenda W. Gillespie
- Sudtida SatayathumSSSudtida Satayathum
- Norbert LameireNLNorbert Lameire
- Akira SaitoASAkira Saito
- Takashi AkibaTATakashi Akiba
- Michel JadoulMJMichel Jadoul
- Nancy GinsbergNGNancy Ginsberg
- Marcia KeenMKMarcia Keen
- Friedrich K. PortFPFriedrich K. Port
- 31 October 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (18) , 1914-1922
Abstract
Background— Patients with end-stage renal disease are at high risk for cardiovascular morbidity and mortality. The aims of the present study were to describe the prevalence of peripheral arterial disease (PAD) and its effects on prognosis and health-related quality of life (HRQOL) in an international cohort of patients on hemodialysis. Methods and Results— Data from the Dialysis Outcomes and Practice Patterns Study (DOPPS), a prospective, international, observational study of hemodialysis patients (n=29 873), were analyzed. Associations between baseline clinical variables and PAD were evaluated by logistic regression analysis. Cox regression models were used to test the association between PAD and risk for all-cause mortality, cardiac mortality, and hospitalization. PAD was diagnosed in 7411 patients (25.3%) with significant geographic variation. Traditional cardiovascular risk factors including age, male sex, diabetes, hypertension, and smoking were identified, together with the duration of hemodialysis, as significant correlates of PAD. Diagnosis of PAD was associated with increased all-cause mortality (hazard ratio [HR]=1.36; P P P P P Conclusions— PAD is common in hemodialysis patients and is associated with increased risk of cardiovascular mortality, morbidity, and hospitalization and reduced HRQOL.Keywords
This publication has 21 references indexed in Scilit:
- Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial DiseaseJACC, 2006
- Ethnicity and Peripheral Arterial DiseaseCirculation, 2005
- Incidence of Atherosclerosis by Race in the Dialysis Morbidity and Mortality StudyJournal of the American Society of Nephrology, 2005
- Survival Advantage of Hispanic Patients Initiating Dialysis in the United States Is Modified by RaceJournal of the American Society of Nephrology, 2005
- Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS)American Journal of Kidney Diseases, 2004
- The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodologyAmerican Journal of Kidney Diseases, 2004
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesCirculation, 2004
- Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS)Kidney International, 2003
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- Morbidity and mortality in dialysis patientsKidney International, 1994